Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

NCT: NCT04217551 · COMPLETED

NCT IDNCT04217551
StatusCOMPLETED
Start Date2020-05-18
Completion2026-02-01
SponsorUniversity of Michigan (OTHER)
First posted
Last updated

Brief Summary

A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

Frequently Asked Questions

What is Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients?

Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients is a clinical trial registered under NCT04217551. Current status: COMPLETED.

What is the status of NCT04217551?

The current status of NCT04217551 (Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients) is: COMPLETED.

When did Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients start?

Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients started on 2020-05-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.